Logo image of GBNH

GREENBROOK TMS INC (GBNH) Stock Fundamental Analysis

NASDAQ:GBNH - Nasdaq - CA3937043097 - Common Stock - Currency: USD

0.121  -0.08 (-40.69%)

After market: 0.1153 -0.01 (-4.71%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GBNH. GBNH was compared to 108 industry peers in the Health Care Providers & Services industry. GBNH may be in some trouble as it scores bad on both profitability and health. GBNH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GBNH had negative earnings in the past year.
GBNH had a negative operating cash flow in the past year.
GBNH had negative earnings in each of the past 5 years.
In the past 5 years GBNH always reported negative operating cash flow.
GBNH Yearly Net Income VS EBIT VS OCF VS FCFGBNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

The Return On Assets of GBNH (-78.11%) is worse than 88.98% of its industry peers.
Industry RankSector Rank
ROA -78.11%
ROE N/A
ROIC N/A
ROA(3y)-46.27%
ROA(5y)-38.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GBNH Yearly ROA, ROE, ROICGBNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 500 -500

1.3 Margins

With a decent Gross Margin value of 44.95%, GBNH is doing good in the industry, outperforming 75.42% of the companies in the same industry.
GBNH's Gross Margin has improved in the last couple of years.
GBNH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y7.57%
GBNH Yearly Profit, Operating, Gross MarginsGBNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40 -60 -80

More info and screens

0

2. Health

2.1 Basic Checks

GBNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
GBNH has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, GBNH has a worse debt to assets ratio.
GBNH Yearly Shares OutstandingGBNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
GBNH Yearly Total Debt VS Total AssetsGBNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -3.13, we must say that GBNH is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -3.13, GBNH is not doing good in the industry: 82.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.13
ROIC/WACCN/A
WACC8.23%
GBNH Yearly LT Debt VS Equity VS FCFGBNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M 80M

2.3 Liquidity

GBNH has a Current Ratio of 0.52. This is a bad value and indicates that GBNH is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.52, GBNH is doing worse than 91.53% of the companies in the same industry.
GBNH has a Quick Ratio of 0.52. This is a bad value and indicates that GBNH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.52, GBNH is not doing good in the industry: 86.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
GBNH Yearly Current Assets VS Current LiabilitesGBNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

6

3. Growth

3.1 Past

GBNH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -49.69%.
The Revenue has grown by 47.06% in the past year. This is a very strong growth!
GBNH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.05% yearly.
EPS 1Y (TTM)-49.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.83%
Revenue 1Y (TTM)47.06%
Revenue growth 3Y24.64%
Revenue growth 5Y38.05%
Sales Q2Q%29.13%

3.2 Future

Based on estimates for the next years, GBNH will show a very strong growth in Earnings Per Share. The EPS will grow by 35.18% on average per year.
GBNH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.01% yearly.
EPS Next Y58.2%
EPS Next 2Y35.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.64%
Revenue Next 2Y13.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GBNH Yearly Revenue VS EstimatesGBNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GBNH Yearly EPS VS EstimatesGBNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GBNH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GBNH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GBNH Price Earnings VS Forward Price EarningsGBNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GBNH Per share dataGBNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as GBNH's earnings are expected to grow with 35.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.18%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GBNH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENBROOK TMS INC

NASDAQ:GBNH (2/23/2024, 8:00:01 PM)

After market: 0.1153 -0.01 (-4.71%)

0.121

-0.08 (-40.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-08 2023-11-08/amc
Earnings (Next)04-15 2024-04-15/amc
Inst Owners2.68%
Inst Owner Change0%
Ins Owners17.86%
Ins Owner Change0%
Market Cap5.18M
Analysts80
Price Target0.66 (445.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.87%
Min EPS beat(2)-25.16%
Max EPS beat(2)19.42%
EPS beat(4)1
Avg EPS beat(4)-92.49%
Min EPS beat(4)-241.74%
Max EPS beat(4)19.42%
EPS beat(8)4
Avg EPS beat(8)-44.04%
EPS beat(12)5
Avg EPS beat(12)-34.69%
EPS beat(16)5
Avg EPS beat(16)-37.93%
Revenue beat(2)1
Avg Revenue beat(2)-1.42%
Min Revenue beat(2)-5.97%
Max Revenue beat(2)3.14%
Revenue beat(4)1
Avg Revenue beat(4)-3.23%
Min Revenue beat(4)-6.06%
Max Revenue beat(4)3.14%
Revenue beat(8)4
Avg Revenue beat(8)-0.36%
Revenue beat(12)4
Avg Revenue beat(12)-2.38%
Revenue beat(16)7
Avg Revenue beat(16)-1.44%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.41
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS1.87
BVpS-1.01
TBVpS-1.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.95%
FCFM N/A
ROA(3y)-46.27%
ROA(5y)-38.54%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.24%
GM growth 5Y7.57%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.35%
Cap/Sales 0.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z -3.13
F-Score4
WACC8.23%
ROIC/WACCN/A
Cap/Depr(3y)0.26%
Cap/Depr(5y)206.71%
Cap/Sales(3y)0.03%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.83%
EPS Next Y58.2%
EPS Next 2Y35.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)47.06%
Revenue growth 3Y24.64%
Revenue growth 5Y38.05%
Sales Q2Q%29.13%
Revenue Next Year6.64%
Revenue Next 2Y13.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-818.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.38%
OCF growth 3YN/A
OCF growth 5YN/A